BIOS Capital Management, LP Long-Term Concentrated

Location: Fort Worth, TX

CIK: 0001813845 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $41.67M (100.0% shares, 0.0% debt)

Holdings (6)

ACTU ACTUATE THERAPEUTICS INC 36.9%

Value $15.38M Shares 10,049,996 Est. Cost — Unrealized —

IRD OPUS GENETICS INC 36.3%

Value $15.14M Shares 3,683,429 Est. Cost — Unrealized —

CGTX COGNITION THERAPEUTICS INC 16.6%

Value $6.9M Shares 6,000,000 Est. Cost — Unrealized —

RNTX REIN THERAPEUTICS INC 7.4%

Value $3.102M Shares 2,982,375 Est. Cost — Unrealized —

LTRN LANTERN PHARMA INC 2.5%

Value $1.04M Shares 249,397 Est. Cost — Unrealized —

INAB IN8BIO INC 0.3%

Value $114K Shares 80,957 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ACTU	ACTUATE THERAPEUTICS INC	10,049,996	$15.38M	36.9%	—	—	COM	005083100
IRD	OPUS GENETICS INC	3,683,429	$15.14M	36.3%	—	—	COM	67577R102
CGTX	COGNITION THERAPEUTICS INC	6,000,000	$6.9M	16.6%	—	—	COM	19243B102
RNTX	REIN THERAPEUTICS INC	2,982,375	$3.102M	7.4%	—	—	COM NEW	00887A204
LTRN	LANTERN PHARMA INC	249,397	$1.04M	2.5%	—	—	COM	51654W101
INAB	IN8BIO INC	80,957	$114K	0.3%	—	—	COM NEW	45674E208